NEWS
9 June 2025
In a pharmaceutical industry under pressure from Annex 1 compliance, accelerated go-to-market timelines, and facility constraints, process cleaning solutions must evolve.
9 June 2025
As the pharmaceutical industry embraces advanced therapies, stringent compliance standards, and digital transformation, traditional process control systems are rapidly becoming obsolete.
9 June 2025
In sterile manufacturing, every detail matters. That is why Fedegari developed the Humanless Handling System.
9 June 2025
In a pharmaceutical manufacturing landscape increasingly driven by regulatory scrutiny, process intensification, and operational flexibility, Fedegari Stopper Processor addresses the critical needs of aseptic manufacturing by combining elastomeric closure treatment and machine parts sterilization in a single, compact solution.
9 June 2025
Scientific research and technological innovation have the power to improve lives: at Fedegari, this belief drives everything we do.
6 June 2025
The Candidates for Rector of the University of Pavia meet at the Fedegari Conference Hall.
20 February 2025
Fedegari’s extensive expertise now offers even greater opportunities to its clients, broadening its value proposition with the addition of No Deviation.
18 December 2024
We use the form of storytelling to share the value of the day of that Oct. 14 in Pavia.
5 December 2024
Fedegari Group is proud to announce the launch of FACE, a strategic joint venture with our partner ACE Technologies.
22 May 2024
Fedegari Group, a manufacturer and service provider of high-performance sterilization systems, today announced its strategic partnership with CAI, a global company that provides technical, operational consulting, and project management services.
19 January 2024
We are delighted to announce that, as of January 1st, Fedegari Group has successfully acquired 100% ownership of Steritec SA.
11 January 2024
Multiply Labs and Fedegari Group Collaborate to Add Sterilization to Automated Cell Therapy Manufacturing for Eliminating Contamination Risks.